News | News By Subject | News by Disease News By Date | Search News

Inflammatory Bowel Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill     6/8/2017
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Seres Therapeutics Snags Monumental $1.9 Billion IBS Deal with Nestlé Health Science     1/11/2016
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
23andMe, Inc., Pfizer Inc. (PFE) Strike Pact To Research The Genetics Of Inflammatory Bowel Disease     8/12/2014
New Direction For Drugmakers Such As Merck & Co., Inc. (MRK), Sanofi (France) (SAN.PA): Seeking Cure For Deadly Bowel Infection     4/14/2014
Takeda's Inflammatory Bowel Drug's Risks Questioned     12/5/2013
BioLineRx Ltd. and Yissum Ltd. Sign a Licensing Agreement for the Development of a Novel Compound for the Treatment of Inflammatory Bowel Disease     11/12/2008
Gene Logic Inc. (GLGC) Says Bowel Disease Drug Shows Positive Results     7/27/2007
Nuvelo, Inc. (NUVO) Partners With Kirin Brewery Co., Ltd. (KNBWY) To Develop NU206, A Lead Compound From Its Secreted Proteins Program     4/4/2005
Rimonyx Pharmaceuticals Ltd. Completes First Private Investment Round And Licenses Lead Inflammatory Bowel Disease Drug Candidate To BioLineRx Ltd. For Continued Development     2/7/2005
Enzo Biochem (ENZ) Reports Interim Results For Clinical Trial Of Alequel, Its Investigational Treatment For Management Of Crohn's Disease     3/11/2004

News from Around the Web
Parasites May Actually Help Stomach And Bowel Diseases, New York University's Langone Medical Center Study     4/15/2016
Does Inflammatory Bowel Disease Discourage Pregnancy? University of Leeds Study     4/8/2016
Gel Eases Inflammatory Bowel Problems, Brigham and Women's Hospital Study     8/14/2015
Growing Human GI Cells May Lead To Personalized Treatments, Washington University in St. Louis Study     8/8/2014
Two Genes Linked To Inflammatory Bowel Disease, University of Cincinnati Study     4/23/2014
Red Meat 'Increases Risk of Bowel Cancer' - World Cancer Research Fund Study Suggests     5/24/2011
Scientists Discover New Drug Target for Inflammatory Bowel Disease: Cytokine (IL-23), Department of Gastroenterology at The Shanghai Tenth People's Study     4/1/2011
Genetic Links Found to Bowel Disease     2/7/2011
New Probiotic Combats Inflammatory Bowel Disease, Northwestern University Study     2/1/2011
Infants' Antibiotic Use Tied to Bowel Disease Risk, University of Manitoba Study     11/1/2010
American College of Gastroenterology: Serrated Adenomas Appear Among IBD Patients, University of Pennsylvania Study     10/22/2010
As Waist Grows, So Does Bowel Cancer Risk, University of Leeds Study     9/20/2010
Studies at University of Udine Offer Encouraging Data On Preventing Crohn's Disease Recurrence     8/6/2010
Genes May Exert Opposite Effects in Diabetes and Inflammatory Bowel Disease, Children's Hospital of Philadelphia Study     3/23/2010
Cannabis Hope for Inflammatory Bowel Disease, Lancaster University Study     12/21/2009

Press Releases
Takeda (TKPYY) And Marvel Custom Solutions Debut The Full IBD Unmasked Graphic Novel Featuring A Team Of Inflammatory Bowel Disease (IBD) Super Heroes     8/2/2017
Vitality Biopharma Releases Positive Results For Treatment Of Inflammatory Bowel Disease     7/19/2017
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Phase II PoC Trial For Inflammatory Bowel Disease Achieves Induction Of Remission In A Majority Of Patients Treated With Brilacidin     7/14/2017
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Completes Treatments In Phase II PoC Trial For Induction Of Remission In Inflammatory Bowel Disease; Topline Results With Endoscopic Response To Be Presented July 13, 2017     6/26/2017
OSE Immunotherapeutics Presents Positive Preclinical Results And Human Ex Vivo Data For OSE-127 (Effi-7) To Support Next Clinical Applications In Inflammatory Bowel Diseases At The Federation Of Clinical Immunology Societies (FOCIS) Conference     6/15/2017
Corrona Announces First Patient Has Enrolled In Its Inflammatory Bowel Disease Registry     6/2/2017
Seattle Children's Brings First-Of-Its-Kind Precision Medicine Clinical Trial To Inflammatory Bowel Disease, Bone Marrow Transplant Patients     5/24/2017
Cellceutix (CTIX) Completes Patient Enrollment Of Final Cohort In Phase II Trial Of Brilacidin For Inflammatory Bowel Disease; Topline Results Anticipated In July     5/18/2017
Cellceutix (CTIX) CEO Discusses Brilacidin Following Interim Trial Results For Treating Oral Mucositis And Inflammatory Bowel Disease     4/10/2017
Simponi Is Sixth Drug In InformTx Therapeutic Drug Monitoring Service From Miraca Life Sciences     3/28/2017
Ferring Pharma Collaborates With ICF On Development Of A Potential New Treatment For Anal Fissures With A Focus On Improving Quality Of Care For IBD Patients     3/15/2017
Akebia (AKBA) Licenses Portfolio Of Novel HIF Compounds From Johnson & Johnson Innovation (JNJ)     2/13/2017
Key Patent Is Issued Covering Protagonist (PTGX)' Alpha4Beta7 Integrin Peptide Inhibitors Including Oral Drug Candidate PTG-100     1/5/2017
The Optical Society Release: New Sensor Integrates Inflammatory Bowel Disease Detection Into Colonoscopy Procedure     1/4/2017
Heptares Scientists Solve Structure Of CCR9 Chemokine Receptor Offering Unique Opportunity To Apply Structure-Based Design Across Chemokine Receptor Family     12/8/2016